These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17064916)

  • 41. Pantolactams as androgen receptor antagonists for the topical suppression of sebum production.
    Sexton KE; Barrett S; Bridgwood K; Carroll M; Dettling D; Du D; Fakhoury S; Fedij V; Hu LY; Kostlan C; Pocalyko D; Raheja N; Smith Y; Shanmugasundaram V; Wade K
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5230-3. PubMed ID: 21831636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression.
    Fuse H; Korenaga S; Sakari M; Hiyama T; Ito T; Kimura K; Kato S
    Prostate; 2007 May; 67(6):630-7. PubMed ID: 17342748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.
    van Straten NC; van Berkel TH; Demont DR; Karstens WJ; Merkx R; Oosterom J; Schulz J; van Someren RG; Timmers CM; van Zandvoort PM
    J Med Chem; 2005 Mar; 48(6):1697-700. PubMed ID: 15771412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
    Nishizaki Y; Ishimoto Y; Hotta Y; Hosoda A; Yoshikawa H; Akamatsu M; Tamura H
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4706-10. PubMed ID: 19592245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    Bioorg Med Chem; 2008 May; 16(10):5490-500. PubMed ID: 18455407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
    Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
    Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of new prostaglandin D₂ receptor antagonists.
    Iwahashi M; Takahashi E; Tanaka M; Matsunaga Y; Okada Y; Matsumoto R; Nambu F; Nakai H; Toda M
    Bioorg Med Chem; 2011 Sep; 19(18):5361-71. PubMed ID: 21885288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tryptophan-containing dipeptide derivatives as potent PPARgamma antagonists: design, synthesis, biological evaluation, and molecular modeling.
    Deng G; Liu Z; Ye F; Luo X; Zhu W; Shen X; Liu H; Jiang H
    Eur J Med Chem; 2008 Dec; 43(12):2699-716. PubMed ID: 18329752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands.
    Van Dort ME; Jung YW
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5285-8. PubMed ID: 15454212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T; Onda K; Hayakawa M; Seki N; Takahashi T; Moritomo H; Suzuki T; Matsui T; Takasu T; Nagase I; Ohta M
    Bioorg Med Chem; 2009 May; 17(9):3283-94. PubMed ID: 19362005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.
    Schlienger N; Lund BW; Pawlas J; Badalassi F; Bertozzi F; Lewinsky R; Fejzic A; Thygesen MB; Tabatabaei A; Bradley SR; Gardell LR; Piu F; Olsson R
    J Med Chem; 2009 Nov; 52(22):7186-91. PubMed ID: 19856921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Photo-inducible cytotoxic and clastogenic activities of 3,6-di-substituted acridines obtained by acylation of proflavine.
    Benchabane Y; Di Giorgio C; Boyer G; Sabatier AS; Allegro D; Peyrot V; De Méo M
    Eur J Med Chem; 2009 Jun; 44(6):2459-67. PubMed ID: 19217190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models.
    Kumar YC; Malviya M; Chandra JN; Sadashiva CT; Kumar CS; Prasad SB; Prasanna DS; Subhash MN; Rangappa KS
    Bioorg Med Chem; 2008 May; 16(9):5157-63. PubMed ID: 18359231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
    Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
    J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cellular conformation-based screen for androgen receptor inhibitors.
    Jones JO; Diamond MI
    ACS Chem Biol; 2008 Jul; 3(7):412-8. PubMed ID: 18582038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents.
    Slee DH; Chen Y; Zhang X; Moorjani M; Lanier MC; Lin E; Rueter JK; Williams JP; Lechner SM; Markison S; Malany S; Santos M; Gross RS; Jalali K; Sai Y; Zuo Z; Yang C; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J
    J Med Chem; 2008 Mar; 51(6):1719-29. PubMed ID: 18307292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and evaluation of substituted 4-alkoxy-2-aminopyridines as novel neuropeptide Y1 receptor antagonists.
    Sato N; Shibata T; Jitsuoka M; Ohno T; Takahashi T; Hirohashi T; Kanno T; Iwaasa H; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1761-4. PubMed ID: 15026066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and pharmacological evaluation of novel arylpiperazine derivatives as nonsteroidal androgen receptor antagonists.
    Kinoyama I; Taniguchi N; Yoden T; Koutoku H; Furutani T; Kudoh M; Okada M
    Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1330-3. PubMed ID: 15516756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening.
    Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.